IOmx Therapeutics

1 follower


iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics.

Headquarters

Munich, Germany

Employees

11-50

Links

Org chart

Apollon Papadimitriou

Collapse
Christine Rothe
Chief Development Officer (CDO)
Nils Debus
Chief Business Officer
Hannes Loferer
SVP & Head of Project Management
Stefan Bissinger
Senior Director - Head Of Preclinical Pharmacology & Biomarker Development
Tillmann Michels
Associate Director Target Discovery
Marisa Stebegg
Biomarker Development Lead
Andreas Bueltmann
Senior Director Science & Innovation